Loading...

OPK OPKO HEALTH INC Company Mergers 8-K Filing

PK H

PK

OPKO HEALTH INC

(OPK)

2025 8-K

Quarterly Results Update

Board Appointment

Financial Results Update

Earnings Announcement

Asset Sale Completion

Financial Statements

Compensatory Arrangements o...

Financial Statements

Financial Results

Investor Conference

Financial Results

Asset Sale Completion

Earnings Reports

Compensation Committee Meeting

Note Purchase Agreement

Annual Meeting of Stockholders

Asset Purchase Agreement

Earnings Report

Departure of Directors

Termination of Share Lendin...

Private Offering

Investor Conferences

Amendment on Stockholder Ad...

Investment in ModeX Therape...

Earnings Reports

Agreement Amendment

Annual Meeting of Stockholders

Compensation Committee Meeting

Earnings Reports

External Links:

On September 15, 2025, OPKO Health, Inc. completed the sale of its BioReference laboratory testing business for $225 million, receiving $192.5 million in cash upon closing.

AI Assistant

OPKO HEALTH INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.